SHELDON RUDISILL: Open Payments
NPI 1033755780 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 20 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $217 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 7 | $113 |
| Collegium Pharmaceutical, Inc. | 4 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| SCILEX PHARMACEUTICALS INC. | 3 | $53 |
| Valinor Pharma, LLC | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: PROLATE, Belbuca, RELISTOR, ZTLido, MOVANTIK, ELYXYB - CELECOXIB, TANLOR, JOURNAVX.
Industry payments across NC — which companies pay providers there.
